Loading market dashboard
Genmab A/S
GMABHealthcareNASDAQDK
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Genmab A/S · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $6.41B | $6.01B - $6.91B | $2.78B | $2.681 | 9 |
| Dec 2029 | $6.20B | $5.80B - $6.67B | $2.69B | $2.493 | 11 |
| Dec 2028 | $6.11B | $6.09B - $6.12B | $2.65B | $2.506 | 18 |
| Dec 2027 | $5.08B | $4.46B - $5.33B | $2.20B | $1.672 | 15 |
| Dec 2026 | $4.33B | $4.22B - $4.40B | $1.88B | $1.151 | 16 |
| Dec 2025 | $3.71B | $3.66B - $3.75B | $1.61B | $1.725 | 12 |
| Dec 2024 | $3.00B | $2.88B - $3.13B | $1.30B | $1.202 | 15 |
| Dec 2023 | $19.02B | $17.81B - $20.49B | $8.25B | $85.106 | 11 |
| Dec 2022 | $2.03B | $1.89B - $2.16B | $985.05M | $1.429 | 6 |
| Dec 2021 | $1.28B | $1.19B - $1.36B | $620.02M | $0.666 | 7 |
| Dec 2020 | $1.61B | $1.50B - $1.71B | $779.70M | $1.178 | 7 |
| Dec 2019 | $748.29M | $696.47M - $794.63M | $362.75M | $0.498 | 6 |